[Double-blind study of the association of sulfamethoxazole and trimethoprim in otorhinolaryngological infections].
D000890:Anti-Infective Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy*; D004338:Drug Combinations; D004357:Drug Synergism; D005493:Folic Acid Antagonists / Q000627:therapeutic use*; D006801:Humans; D010031:Otitis / Q000188:drug therapy; D010038:Otorhinolaryngologic Diseases / Q000188:drug therapy*; D010612:Pharyngitis / Q000188:drug therapy; D011743:Pyrimidines / Q000627:therapeutic use*; D012220:Rhinitis / Q000188:drug therapy; D012852:Sinusitis / Q000188:drug therapy; D013420:Sulfamethoxazole / Q000627:therapeutic use*; D014295:Trimethoprim / Q000627:therapeutic use
D000890:Anti-Infective Agents; D004338:Drug Combinations; D005493:Folic Acid Antagonists; D011743:Pyrimidines; D014295:Trimethoprim; D013420:Sulfamethoxazole
Essai en double aveugle de l'association de sulfaméthoxazole et de triméthoprime dans les infections oto-rhino-laryngologiques.